| Literature DB >> 27416740 |
Young Soo Kim1, Dong-Hee Lee1, Hiun Suk Chae1, Tae-Kyu Lee1, Tae Seo Sohn1, Seong Cheol Jeong1, Hee Yeon Kim1, Jae-Im Lee1, Jae Yen Song1, Chang Dong Yeo1, Young Bok Lee1, Hyo-Suk Ahn1, Mihee Hong1, Kyungdo Han2.
Abstract
OBJECTIVES: The aim of this study was to determine whether chronic kidney disease (CKD) is associated with hearing thresholds in the nationwide, large-scaled Korean population.Entities:
Keywords: Adult; Albuminuria; Epidemiologic Studies; Hearing Loss; Korea
Year: 2016 PMID: 27416740 PMCID: PMC4996098 DOI: 10.21053/ceo.2015.01368
Source DB: PubMed Journal: Clin Exp Otorhinolaryngol ISSN: 1976-8710 Impact factor: 3.372
Baseline characteristics of 9,788 participants in this study
| Characteristic | Male | Female | ||||||
|---|---|---|---|---|---|---|---|---|
| Hearing category | Hearing category | |||||||
| 1 | 2 | 3 | 1 | 2 | 3 | |||
| No. of subjects | 3,677 | 385 | 325 | 4,720 | 389 | 302 | ||
| Age (yr) | 42.1±0.3 | 57.8±1.0 | 67.6±1.0 | <0.001 | 45.0±0.3 | 61.7±1.0 | 71.9±0.8 | <0.001 |
| Education, ≥high-school graduation (%) | 82.8±0.8 | 53.5±3.2 | 33.6±3.4 | <0.001 | 68.6±1.0 | 29.9±3.2 | 12.0±3.1 | <0.001 |
| Current smoker, yes (%) | 42.5±1.0 | 41.2±3.7 | 28.9±3.3 | 0.006 | 5.6±0.4 | 4.2±1.6 | 3.6±1.2 | 0.393 |
| Heavy alcohol drinker, >30 g/day (%) | 18.4±0.9 | 17.6±3.1 | 13.8±2.8 | 0.449 | 2.2±0.3 | 0.5±0.3 | 0.4±0.3 | 0.002 |
| Moderate physical activity, yes (%) | 22.7±0.8 | 18.9±2.4 | 17.9±2.9 | 0.131 | 15.6±0.7 | 12.9±2.4 | 8.9±2.6 | 0.079 |
| Hypertension, yes (%) | 26.2±0.9 | 45.9±3.3 | 49.3±3.4 | <0.001 | 20.9±0.9 | 47.8±3.1 | 67.9±3.9 | <0.001 |
| Metabolic syndrome, yes (%) | 24.9±0.9 | 32.3±3.2 | 34.0±3.5 | 0.003 | 25.2±0.8 | 46.1±3.4 | 53.9±3.4 | <0.001 |
| Noise exposure/inside, yes (%) | 18.8±0.9 | 22.2±3.2 | 25.5±3.4 | 0.089 | 7.7±0.6 | 5.9±1.3 | 11.2±2.7 | 0.159 |
| Noise exposure/outside, yes (%) | 2.7±0.4 | 3.5±1.1 | 3.4±1.6 | 0.766 | 2.0±0.3 | 2.0±0.9 | 1.8±1.3 | 0.980 |
| Explosive noise, yes (%) | 45.5±1.9 | 41.5±3.5 | 39.8±3.9 | 0.183 | 3.1±0.4 | 7.4±1.5 | 10.8±2.7 | <0.001 |
| Body mass index (kg/m2) | 24.2±0.1 | 24.0±0.3 | 23.4±0.2 | 0.002 | 23.4±0.1 | 24.0±0.2 | 23.7±0.3 | 0.019 |
| Waist circumference (cm) | 84.2±0.2 | 85.1±0.7 | 84.6±0.7 | 0.439 | 78.1±0.2 | 81.5±0.6 | 81.2±0.8 | <0.001 |
| Fasting plasma glucose (mg/dL) | 97.7±0.4 | 103±1.5 | 102.7±1.6 | 0.001 | 94.6±0.4 | 100±1.8 | 103.5±1.6 | <0.001 |
| HbA1c (%) | 5.7±0.0 | 5.9±0.1 | 6.0±0.1 | <0.001 | 5.6±0.0 | 5.9±0.1 | 6.1±0.1 | <0.001 |
| Glomerular filtration rate (mL/min/1.73 m2) | 93.4±0.3 | 87.1±1.4 | 83.4±1.2 | <0.001 | 97.9±0.4 | 88.6±1.2 | 83.7±1.3 | <0.001 |
| Chronic kidney disease, yes (%) | 1.2±0.2 | 7.0±1.5 | 8.6±1.7 | <0.001 | 1.3±0.2 | 6.2±1.4 | 8.8±1.7 | <0.001 |
| Logarithm of urine albumin/creatinine ratio | 1.4±0.0 | 1.8±0.1 | 2.1±0.1 | <0.001 | 1.6±0.0 | 2.1±0.1 | 2.5±0.1 | <0.001 |
| Urine albumin/creatinine ratio (mg/g) | <0.001 | <0.001 | ||||||
| <5 | 74.5±0.9 | 60.4±3.2 | 52.8±3.5 | 11.1±0.6 | 17.2±2.5 | 13.7±2.3 | ||
| ≥5 and <10 | 7.2±0.5 | 8.9±1.7 | 11.4±2.4 | 2.6±0.3 | 3.1±1.0 | 7.1±2.0 | ||
| ≥10 and <20 | 4.6±0.4 | 10.5±1.8 | 14.9±2.2 | 64.9±1.0 | 46.3±3.2 | 30.4±3.3 | ||
| ≥20 and <30 | 17.7±0.7 | 21.1±2.5 | 21.6±3.0 | 8.5±0.5 | 13.3±2.0 | 17.7±2.9 | ||
| ≥30 | 2.8±0.3 | 6.3±1.6 | 7.2±1.9 | 6.2±0.4 | 13.0±1.9 | 23.1±2.9 | ||
Values are presented as number or mean±standard deviation.
Linear regression analysis of the association between urine albumin/creatinine ratio and PTA average of better ear at specific frequency
| PTA average (dB HL) of better ear | Male | Female | ||
|---|---|---|---|---|
| Pearson correlation coefficient | Pearson correlation coefficient | |||
| 0.5 kHz | 0.147 | <0.001 | 0.194 | <0.001 |
| 1 kHz | 0.194 | <0.001 | 0.208 | <0.001 |
| 2 kHz | 0.196 | <0.001 | 0.191 | <0.001 |
| 3 kHz | 0.200 | <0.001 | 0.221 | <0.001 |
| 4 kHz | 0.187 | <0.001 | 0.225 | <0.001 |
| 6 kHz | 0.202 | <0.001 | 0.227 | <0.001 |
PTA, pure tone audiogram.
Logistic regression of urine ACR and hearing loss. Regression models and odds ratio in subjects with hearing loss in one or both ears
| Urine ACR (mg/g) | Male | Female | ||||
|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | |
| Hearing loss in one or both ears | ||||||
| ≥30 | 1.248 (0.849–1.833) | 1.189 (0.785–1.800) | 1.324 (0.865–2.026) | 1.674 (1.200–2.336) | 1.612 (1.146–2.266) | 1.674 (1.180–2.375) |
| ≥20 and <30 | 1.098 (0.642–1.875) | 1.086 (0.639–1.847) | 1.132 (0.663–1.933) | 1.614 (1.014–2.570) | 1.601 (1.002–2.558) | 1.636 (1.017–2.633) |
| ≥10 and <20 | 0.983 (0.657–1.469) | 0.919 (0.617–1.369) | 0.932 (0.616–1.411) | 1.416 (1.020–1.965) | 1.327 (0.943–1.865) | 1.391 (0.985–1.963) |
| ≥5 and <10 | 1.068 (0.736–1.550) | 1.028 (0.701–1.509) | 1.100 (0.743–1.628) | 1.281 (0.927–1.769) | 1.272 (0.907–1.785) | 1.287 (0.914–1.811) |
| <5 | Reference | Reference | Reference | Reference | Reference | Reference |
| Hearing loss in both ears | ||||||
| ≥30 | 1.190 (0.750–1.888) | 1.098 (0.679–1.774) | 1.092 (0.656–1.817) | 2.065 (1.346–3.166) | 2.202 (1.410–3.440) | 2.229 (1.407–3.531) |
| ≥20 and <30 | 1.640 (0.796–3.380) | 1.788 (0.868–3.680) | 1.741 (0.841–3.605) | 1.545 (0.733–3.257) | 1.584 (0.723–3.469) | 1.644 (0.743–3.640) |
| ≥10 and <20 | 1.043 (0.569–1.909) | 1.094 (0.587–2.038) | 1.046 (0.549–1.994) | 1.689 (1.028–2.775) | 1.512 (0.872–2.623) | 1.589 (0.917–2.753) |
| ≥5 and <10 | 0.797 (0.494–1.285) | 0.737 (0.440–1.235) | 0.736 (0.434–1.247) | 1.366 (0.873–2.137) | 1.404 (0.865–2.279) | 1.411 (0.868–2.294) |
| <5 | Reference | Reference | Reference | Reference | Reference | Reference |
Values are presented as odds ratio (95% confidence interval). The reference category was urine ACR <5 mg/g.
Model 1, adjusted for age and BMI; Model 2, adjusted for age, BMI, smoke, alcohol, physical activity, education, and income; Model 3, adjusted for age, BMI, smoke, alcohol, physical activity, education, income, stress, and metabolic syndrome.
ACR, albumin/creatinine ratio; BMI, body mass index.
Fig. 1.Relationships between the categories of urine albumin-to-creatinine ratio (ACR) and prevalence of hearing loss according to gender. The degree of hearing loss was significantly different according to categories of urine ACR in males and females subgroups (P<0.0001 in both subgroups).